Real-world evidence (RWE) is health care information derived from real-world data (RWD). It can be generated through various study designs or analyses, including pragmatic clinical trials, observational studies, and health surveys. In the context of RWE, patient recruitment plays a significant role, as the data collected from these individuals helps in understanding the effectiveness, safety, and usage of medical products in the real world.
Traditional Patient Recruitment: In traditional methods, patient recruitment generally happens through methods like physician referrals, media advertising, patient registries, and patient advocacy groups. This method can be time-consuming, costly, and sometimes inefficient, as it often relies on manual efforts. It can also be challenging to find patients who fit specific inclusion and exclusion criteria for a particular study.
AI-Enabled Recruitment: Artificial intelligence (AI) has started transforming patient recruitment in many ways. AI can analyze vast amounts of real-world data from electronic health records (EHRs), medical claims, health surveys, and other digital health platforms to identify eligible patients rapidly. This approach reduces the recruitment timeline and the costs associated with patient enrollment.
AI algorithms can predict the likelihood of patients participating in the study, improving the precision of recruitment. They can also monitor and analyze patient behavior, enabling the refinement of recruitment strategies in real-time. AI can further enhance the diversity of recruited patients by considering a wide range of demographic and geographic factors, leading to a more inclusive and representative study.
AI-enabled recruitment can also help in mitigating potential biases in patient selection by utilizing a data-driven approach. By analyzing historical clinical trial data, AI models can identify patterns and biases in previous studies and correct them in future ones. Furthermore, AI can help in patient retention by predicting the potential drop-out risks and enabling timely intervention.
In conclusion, while traditional methods are essential and remain relevant in certain contexts, AI-enabled recruitment offers the possibility of increased speed, reduced costs, and improved diversity and representativeness of patients in studies generating real-world evidence.
Share this story...
Real World Evidence (RWE) 101 – Is ‘Retrospective Data’ the Same as ‘Secondary Use of Existing Data’?
RWE 101 - Is 'Retrospective Data' the Same as 'Secondary Use of Existing Data'? Retrospective data generally refers to data that has already been collected for another purpose [...]
Real World Evidence (RWE) 101 – EHDS and GDPR – How does GDPR support the secondary use of existing health data for the purposes of scientific research?
RWE 101 - EHDS and GDPR - How does GDPR support the secondary use of existing health data for the purposes of scientific research? The GDPR (General Data [...]
Real World Evidence (RWE) 101 – Federated Clinical Data
RWE 101 - Federated Clinical Data Federated clinical data refers to clinical data that is distributed across multiple organizations or entities, such as hospitals, clinics, research institutions, [...]
Real World Evidence (RWE) 101 – The European Health Data Space (EHDS)
RWE 101 - The European Health Data Space (EHDS) The European Health Data Space (EHDS) is a proposed initiative by the European Union to create a secure and [...]
Real World Evidence (RWE) 101 – The Impact of the EMAs Data Quality Framework on RWE
RWE 101 - The Impact of the EMAs Data Quality Framework on RWE The EMA (European Medicines Agency) data quality framework provides a set of guidelines and principles [...]
Real World Evidence (RWE) 101 – DARWIN-EU
RWE 101 - DARWIN-EU DARWIN-EU is a project that aims to establish a sustainable platform for generating and using real-world evidence (RWE) to support decision-making in healthcare [...]







